Acting on insulin
Tuesday, 11 November, 2008
A PhD student from the Garvan Institute in Sydney has discovered a novel action for insulin, describing a new role in glucose uptake.
Freddy Yip and colleagues from the Garvan’s diabetes and obesity research program have found that a member of the myosin motor protein family, 1c, undergoes increased phosphorylation in response to insulin.
Myo1c is thought to play a role in delivering the glucose transporter GLUT4 to the plasma membrane in fat cells.
For people with type 2 diabetes, the team believes there may be blockages in the signal between insulin and Myo1c, perhaps leading to insulin resistance.
The research is published in the November 5 issue of Cell Metabolism [doi:10.1016/j.cmet.2008.09.011].
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
Alliance seeks to boost regional capacity in clinical trials
Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...
Lipid science receives new Australia-led online hub
The Lipid Network launched this month to build links between researchers, clinicians and industry...
